"I guess it's because there have been reputable third

New Post Public Reply Private Reply Replies (1) Message Board
PaperProphet techisbest #10366
"I guess it's because there have been reputable third parties involved all along the way suggesting there is more to the story than a complete fabrication."

Sure. JBI latches on to any name it can for 'credibility'. The NYDEC only issued a permit to burn plastic off gasses and that was used for credibility. RockTenn was offered a no-risk deal and would be paid a portion of revenues. There was no downside so RockTenn took the deal, JBI used RockTenn's name and the deal was then abandoned. Al Sousa struck a joint venture but JBI stiffed him so he ended up suing. Same with the other joint ventures and Mr. Seneca from Pak-it...they struck a deal but ended up suing JBI when JBI didn't deliver. Madison County was going to deliver plastic for free just to try to be green...and JBI stiffed them resulting in breach of that contract. PIPE investors who invested on the basis of media credits and $10/bbl crude oil were defrauded. Crayola, Javaco, all ended.

Yes, there were a lot of entities who struck deals with Mr. Bordynuik. I think Mr. Heddle is the only one who is sticking by him through thick and thin...and Mr. Heddle withheld material information from investors for six months so it's starting to look like Mr. Bordynuik and Mr. Heddle are getting tight.

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Brixton Metals Expands Thorn Project with New Mineral Claims

Updated Category News Views 198

Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...

Continue Reading
Nutex Health Awaits Q2 Results Amid Regulatory Hurdles

Updated Category News Views 20

Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...

Continue Reading
Arvore Partners LP Announces Impressive October Distribution

Updated Category News Views 183

Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...

Continue Reading
Key Insights on Marathon Petroleum's Upcoming Earnings Call

Updated Category News Views 101

An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...

Continue Reading
Revolutionizing Male Infertility Research with PacBio's Revio

Updated Category News Views 80

Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....

Continue Reading